03/15/2024 3:10 PM | Assembly Biosciences (Issuer) Cook Robert Donald II (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/19/2024 10:01 AM | Assembly Biosciences (Issuer) Schornstein Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 3:12 PM | Assembly Biosciences (Subject) Schornstein Alexander (Filed by)
| Form SC 13D/A | |
11/21/2023 3:05 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:15 PM | Assembly Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023 11:38 AM | Assembly Biosciences (Issuer) Schornstein Alexander (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/25/2023 6:15 PM | Assembly Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
|
10/25/2023 4:18 PM | Assembly Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D | |
10/17/2023 6:10 AM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 3:15 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:18 PM | Assembly Biosciences (Subject) Okazaki Jason A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023 6:20 PM | Assembly Biosciences (Subject) Delaney William E IV (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 5:34 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:01 PM | Assembly Biosciences (Subject) Delaney William E IV (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 5:04 PM | Assembly Biosciences (Subject) Okazaki Jason A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023 6:03 PM | Assembly Biosciences (Issuer) Okazaki Jason A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:04 PM | Assembly Biosciences (Issuer) Delaney William E IV (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 4:48 PM | Assembly Biosciences (Subject) Delaney William E IV (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023 3:40 PM | Assembly Biosciences (Issuer) RINGO WILLIAM R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 3:30 PM | Assembly Biosciences (Issuer) Mahony Susan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 3:30 PM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2023 3:35 PM | Assembly Biosciences (Issuer) McHutchison John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 3:15 PM | Assembly Biosciences (Issuer) Consylman Gina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 3:20 PM | Assembly Biosciences (Issuer) Houghton Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:05 PM | Assembly Biosciences (Issuer) Delaney William E IV (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:10 PM | Assembly Biosciences (Issuer) Bjorkquist Jeanette M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:15 PM | Assembly Biosciences (Issuer) McHutchison John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 5:30 PM | Assembly Biosciences (Subject) McHutchison John G (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023 5:33 PM | Assembly Biosciences (Subject) Okazaki Jason A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023 5:35 PM | Assembly Biosciences (Subject) Delaney William E IV (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023 3:31 PM | Assembly Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2023 11:15 PM | Assembly Biosciences (Filer)
| Form EFFECT | |
03/31/2023 3:35 PM | Assembly Biosciences (Issuer) Delaney William E IV (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |